Black Diamond Therapeutics, Inc.·4

Sep 22, 5:45 PM ET

Raman Prakash 4

4 · Black Diamond Therapeutics, Inc. · Filed Sep 22, 2025

Insider Transaction Report

Form 4
Period: 2025-09-19
Transactions
  • Award

    Common Stock

    2025-09-19$3.35/sh+3,843$12,87426,362 total
Footnotes (2)
  • [F1]These shares were issued in accordance with the Issuer's Fifth Amended and Restated Non-Employee Director Compensation Policy, pursuant to which the Reporting Person elected to receive shares of the Issuer's common stock in lieu of cash compensation for annual services as a non-employee director of the Issuer.
  • [F2]The price reported in Column 4 is based upon the closing market price of the Issuer's common stock on September 18, 2025.

Documents

1 file
  • 4
    form4-09222025_090933.xmlPrimary